GAITHERSBURG, Md., Dec 11 - Female Health Co's new version of its female condom won crucial backing from a U.S. Food and Drug Administration advisory panel on Thursday.
The FDA panel of outside advisers, in a 15-0 vote, said the company's data supported FDA approval of the FC2 Female Condom as long as some changes were made to the product's label.
The company is seeking to market the new version as a method to prevent sexually transmitted diseases and pregnancy. The FDA usually follows its panel's advice.
If you believe an article violates your rights or the rights of others, please contact us.